Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery

British Journal of Pharmacology

Volumn 161, Issue 1, 2010, Pages 176-192

  Mair, K M ^a   Robinson, E ^b   Kane, K A ^c   Pyne, S ^c   Brett, R R ^c   Pyne, N J ^c   Kennedy, S ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

cannabinoids; sphingosine kinase; sphingosine 1 phosphate

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; CANNABINOID 2 RECEPTOR; CYCLOOXYGENASE 2; DEXANABINOL; INDOMETACIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL TONE; CELL STRAIN HEK293; CONTROLLED STUDY; CORONARY ARTERY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEART PROTECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MALE; MYOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; ARACHIDONIC ACIDS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR AGENTS; CELL LINE; CORONARY VESSELS; HUMANS; INDOLES; INDOMETHACIN; LYSOPHOSPHOLIPIDS; MALE; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2; SPHINGOSINE; TETRAHYDROCANNABINOL; VASODILATION;

EID: 77955783213     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00878.x     Document Type: Article

References (48)

1. Alemany R, Van Koppen CJ, Danneberg K, Ter Braak M, Meyer Zu Heringdorf D (2007). Regulation and functional roles of sphingosine kinases. Naunyn Schmiedebergs Arch Pharmacol 374 : 413 428.
2. Alewijnse AE, Peters SL, Michel MC (2004). Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites. Br J Pharmacol 143 : 666 684.
3. th edn. Br J Pharmacol 158 (Suppl. 1 S1 S254.
4. Ancellin N, Colmont C, Su J, Li Q, Mittereder N, Chae SS et al. (2002). Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J Biol Chem 277 : 6667 6675.
5. Blazquez C, Sanchez C, Daza A, Galve-Roperh I, Guzman M (1999). The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme. J Neurochem 72 : 1759 1768.
6. Chun J, Goetzl EJ, Hla T, Igarashi Y, Lynch KR, Moolenaar W et al. (2002). International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol Rev 54 : 265 269.
7. Coussin F, Scott RH, Wise A, Nixon GF (2002). Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: differential role in vasoconstriction. Circ Res 91 : 151 157.
8. Felder CC, Glass M (1998). Cannabinoid receptors and their endogenous agonists. Annu Rev Pharmacol Toxicol 38 : 179 200.
9. French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JLM et al. (2003). Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 63 : 5962 5969.
10. Galve-Roperh I, Sanchez C, Cortes ML, Gomez Del Pulgar T, Izquierdo M, Guzman M (2000). Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 6 : 313 319.
11. Giuliano M, Calvaruso G, Pellerito O, Portanova P, Carlisi D, Vento R et al. (2006). Anandamide-induced apoptosis in Chang liver cells involves ceramide and JNK/AP-1 pathway. Int J Mol Med 17 : 811 819.
12. Grainger J, Boachie-Ansah G (2001). Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. Br J Pharmacol 134 : 1003 1012.
13. 2 receptors in the rat heart. Eur J Pharmacol 579 : 246 252.
14. Hemmings DG (2006). Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine. Naunyn Schmiedebergs Arch Pharmacol 373 : 18 29.
15. Hemmings DG, Xu Y, Davidge ST (2004). Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats. Br J Pharmacol 143 : 276 284.
16. Herradon E, Martin MI, Lopez-Miranda V (2007). Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta. Br J Pharmacol 152 : 699 708. (Pubitemid 350034972)
17. 2+ influx. Br J Pharmacol 139 : 585 597.
18. Ho WS, Randall MD (2007). Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. Br J Pharmacol 150 : 641 651.
19. Howlett AC, Qualy JM, Khachatrian LL (1986). Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 29 : 307 313.
20. Igarashi J, Michel T (2000). Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction. J Biol Chem 275 : 32363 32370.
21. Igarashi J, Bernier SG, Michel T (2001). Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. Differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J Biol Chem 276 : 12420 12426.
22. Ikeda Y, Ohashi K, Shibata R, Pimentel DR, Kihara S, Ouchi N et al. (2008). Cyclooxygenase-2 induction by adiponectin is regulated by a sphingosine kinase-1 dependent mechanism in cardiac myocytes. FEBS Lett 582 : 1147 1150.
23. Jarai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR et al. (1999). Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA 96 : 14136 14141.
24. Kobayashi N, Nishi T, Hirata T, Kihara A, Sano T, Igarashi Y et al. (2006). Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner. J Lipid Res 47 : 614 621.
25. Long JS, Natarajan V, Tigyi G, Pyne S, Pyne NJ (2006). The functional PDGFbeta receptor-S1P1 receptor signaling complex is involved in regulating migration of mouse embryonic fibroblasts in response to platelet derived growth factor. Prostaglandins Other Lipid Mediat 80 : 74 80.
26. 2+ signals triggered by different phospholipid pathways in antigen stimulation of human mast cells. J Biol Chem 277 : 17255 17262.
27. Mukhopadhyay S, Chapnick BM, Howlett AC (2002). Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. Am J Physiol Heart Circ Physiol 282 : H2046 H2054.
28. Mulvany MJ, Halpern W (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41 : 19 26.
29. Nofer JR, Van Der Giet M, Tolle M, Wolinska I, Von Wnuck Lipinski K, Baba HA et al. (2004). HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S. J Clin Invest 113 : 569 581.
30. Offertaler L, Mo FM, Batkai S, Liu J, Begg M, Razdan RK et al. (2003). Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol Pharmacol 63 : 699 705.
31. Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T (2007). Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun 362 : 928 934.
32. O'Sullivan SE, Kendall DA, Randall MD (2004). Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries. Br J Pharmacol 142 : 435 442.
33. Paugh SW, Cassidy MP, He H, Milstien S, Sim-Selley LJ, Spiegel S et al. (2006). Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4- octylphenylethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor. Mol Pharmacol 70 : 41 50.
34. Peters SL, Alewijnse AE (2007). Sphingosine-1-phosphate signaling in the cardiovascular system. Curr Opin Pharmacol 7 : 186 192.
35. Pitson SM, Moretti PA, Zebol JR, Lynn HE, Xia P, Vadas MA et al. (2003). Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J 22 : 5491 5500.
36. Pratt PF, Hillard CJ, Edgemond WS, Campbell WB (1998). N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor. Am J Physiol 274 : H375 H381.
37. 2 release in airway smooth muscle. Biochem J 328 : 689 694.
38. Pyne S, Lee SC, Long J, Pyne NJ (2009). Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingosine 1-phosphate signalling in health and disease. Cell Signal 21 : 14 21.
39. Romano MR, Lograno MD (2006). Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels. Br J Pharmacol 147 : 917 925.
40. Roviezzo F, Bucci M, Delisle C, Brancaleone V, Di Lorenzo A, Mayo IP et al. (2006). Essential requirement for sphingosine kinase activity in eNOS-dependent NO release and vasorelaxation. Faseb J 20 : 340 342.
41. Sanchez T, Hla T (2004). Structural and functional characteristics of S1P receptors. J Cell Biochem 92 : 913 922.
42. Sarkar S, Maceyka M, Hait NC, Paugh SW, Sankala H, Milstien S et al. (2005). Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells. FEBS Lett 579 : 5313 5317.
43. Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI et al. (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 129 : 227 230.
44. Sukocheva O, Wadham C, Holmes A, Albanese N, Verrier E, Feng F et al. (2006). Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J Cell Biol 173 : 301 310.
45. Taha TA, Hannun YA, Obeid LM (2006). Sphingosine kinase: biochemical and cellular regulation and role in disease. J Biochem Mol Biol 39 : 113 131.
46. Venkataraman K, Thangada S, Michaud J, Oo ML, Ai Y, Lee YM et al. (2006). Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. Biochem J 397 : 461 471.
47. White R, Ho WS, Bottrill FE, Ford WR, Hiley CR (2001). Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br J Pharmacol 134 : 921 929.
48. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V et al. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400 : 452 457.